[November 07, 2005]

Former Quintiles Executive Dr. Graham Bunn Joins Medidata Solutions as Vice President of Strategic Alliances

NEW YORK --(Business Wire)-- Nov. 7, 2005 --

E-Clinical & CRO Expert to Drive Partner Relationships, Facilitate Delivery of Products, Services & Support in EMEA

Medidata Solutions, a global provider of electronic clinical data capture, management and reporting solutions, today announced the appointment of Dr. Graham Bunn as vice president of strategic alliances for EMEA. An industry luminary and early pioneer of EDC technologies, Bunn brings more than 15 years of experience delivering strategic electronic data capture and management solutions to pharmaceutical companies worldwide.

Prior to joining Medidata, Dr. Bunn served as global vice president of e-clinical business development at Quintiles, a leading contract research organization providing a range of pharmaceutical services. After spending 10 years in various IT, business solutions and pre-sales roles at Quintiles in the 1990s, Bunn returned to Quintiles in 2001 to lead its global implementation of EDC technology and develop e-clinical processes.

"Graham has spent years educating the pharmaceutical industry about the business benefits of implementing strategic e-clinical management solutions," said Tarek Sherif, Medidata Solutions CEO. "As Medidata continues to expand, Graham's experience working closely with sponsors and various operational groups to ensure successful deployments and meet a wide range of customer needs will be invaluable to our efforts in researching, initiating and maintaining our partner relationships. Medidata's continued ability to attract highly regarded professionals like Graham points to our leadership position in this market and to the strength of the executive team that we have been able to assemble since our inception."

In his new role as vice president of strategic alliances for EMEA, Dr. Bunn will be responsible for developing and managing relationships with various partners and supporting the sales and delivery of Medidata products and services in Europe and in other regions. He will also take a leading role in Medidata's ASPire to Win program in Europe, a non-exclusive application service provider (ASP) partnership and business model which enables CROs to become Medidata Rave-certified and generate new revenue streams through Medidata's comprehensive electronic clinical technology. This program was established January of 2005 and lists ICON as its charter client.

"Although the evolution of EDC has brought a range of products that attempt to streamline processes and reduce costs, Medidata stands out as the only company that has succeeded in providing an e-clinical platform that truly helps sponsors overcome the market, regulatory and competitive challenges they face today," said Bunn. "I look forward to fostering new partner relationships and contributing to Medidata's technology innovations, corporate growth and industry accomplishments as a member of its talented management team."

About Medidata Solutions Worldwide

Medidata Solutions helps the world's leading pharmaceutical, biotechnology and medical device companies realize the maximum potential value from their clinical research investments. Working with companies large and small, Medidata Solutions helps accelerate the process of bringing life-enhancing treatments to market - on five continents and in more than 70 countries. Innovative process design, technology and services can streamline clinical trials by providing early visibility to clinical data for faster decision-making, optimized resources and lower execution risk. Medidata Solutions' broad client base and deep clinical experience provide value for the world's leading pharmaceutical, biotechnology and medical device companies, expertise in more than 20 therapeutic areas, projects in Phase I, II, III, IV, registries and surveillance, and studies with thousands of investigators and tens-of-thousands of subjects. To learn more about Medidata Solutions, please visit www.mdsol.com.

[ Back To TMCnet.com's Homepage ]

Discussions: